(Q35215407)

7 August 2017

title

Pharmacokinetics of itraconazole and hydroxyitraconazole in healthy subjects after single and multiple doses of a novel formulation (English)

1 reference

7 August 2017

1 reference

Mouton JW

1

1 reference

7 August 2017

van Peer A

2

1 reference

7 August 2017

de Beule K

3

1 reference

7 August 2017

Van Vliet A

4

1 reference

7 August 2017

Donnelly JP

5

1 reference

7 August 2017

Soons PA

6

1 reference

7 August 2017

language of work or name

English

0 references

publication date

18 September 2006

1 reference

7 August 2017

number of pages

7

1 reference

Antimicrobial Agents and Chemotherapy

inferred from page(s)

published in

1 reference

7 August 2017

volume

50

1 reference

7 August 2017

issue

12

1 reference

7 August 2017

page(s)

4096-4102

1 reference

Pharmacokinetics of intravenous itraconazole in stable hemodialysis patients.

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693991

Pharmacokinetics and safety of a 7-day administration of intravenous itraconazole followed by a 14-day administration of itraconazole oral solution in patients with hematologic malignancy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693991

Optimisation of itraconazole therapy using target drug concentrations.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693991

Enhanced bioavailability of itraconazole in hydroxypropyl-beta-cyclodextrin solution versus capsules in healthy volunteers.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693991

Concentrations in plasma and safety of 7 days of intravenous itraconazole followed by 2 weeks of oral itraconazole solution in patients in intensive care units

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693991

Effect of a cola beverage on the bioavailability of itraconazole in the presence of H2 blockers

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693991

Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693991

Pharmacokinetics of itraconazole following oral administration to normal volunteers

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693991

Comparison of Azoles against Aspergilli in vitro and in an Experimental Model of Pulmonary Aspergillosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693991

Intravenous itraconazole for prophylaxis of systemic fungal infections in patients with acute myelogenous leukemia and high-risk myelodysplastic syndrome undergoing induction chemotherapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693991

Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693991

Nanosizing: a formulation approach for poorly-water-soluble compounds

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693991

Pharmacokinetics of intravenous itraconazole followed by itraconazole oral solution in patients with human immunodeficiency virus infection

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693991

Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693991

A pharmacokinetic study of intravenous itraconazole followed by oral administration of itraconazole capsules in patients with advanced human immunodeficiency virus infection

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693991

Food interaction and steady-state pharmacokinetics of itraconazole oral solution in healthy volunteers.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693991

Repeated-dose pharmacokinetics of an oral solution of itraconazole in infants and children.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693991

Pharmacokinetics of itraconazole (oral solution) in two groups of human immunodeficiency virus-infected adults with oral candidiasis

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693991

Influence of concomitant food intake on the gastrointestinal absorption of fluconazole and itraconazole in Japanese subjects

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693991

Oral and intravenous itraconazole for systemic fungal infections in neutropenic haematological patients: meeting report. London, United Kingdom, 20 June 1998

26 September 2018

1 reference

12 December 2020

Determination of itraconazole in plasma and animal tissues by high-performance liquid chromatography

1 reference

12 December 2020

Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole

1 reference

12 December 2020

Protein binding of itraconazole and fluconazole in patients with cancer

1 reference

12 December 2020

Marked intra- and inter-patient variability of itraconazole steady state plasma concentrations

1 reference

12 December 2020

Influence of an acidic beverage (Coca-Cola) on the absorption of itraconazole

1 reference

12 December 2020

Plasma itraconazole concentrations in patients with neutropenia: advantages of a divided daily dosage regimen

1 reference

12 December 2020

Serum protein binding of itraconazole and fluconazole in patients with diabetes mellitus

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.00630-06

1 reference

7 August 2017

1 reference

7 August 2017

1 reference